Sanara MedTech Inc.
SMTI
$22.93
-$0.24-1.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.62% | 4.72% | 21.51% | 28.14% | 26.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.62% | 4.72% | 21.51% | 28.14% | 26.42% |
| Cost of Revenue | 4.83% | -16.66% | -5.91% | -3.55% | -2.91% |
| Gross Profit | 19.80% | 6.71% | 24.29% | 31.64% | 29.75% |
| SG&A Expenses | 14.39% | -0.72% | 14.11% | 13.69% | 18.14% |
| Depreciation & Amortization | -15.37% | 260.91% | -12.34% | 0.79% | -37.22% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.25% | 4.74% | 11.96% | 12.16% | 12.29% |
| Operating Income | 220.61% | 4.49% | 277.80% | 98.92% | 151.68% |
| Income Before Tax | 164.08% | -218.47% | 562.33% | 42.81% | 65.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 164.08% | -218.47% | 562.33% | 42.81% | 65.50% |
| Earnings from Discontinued Operations | 102.10% | 79.67% | -1,066.35% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.00% | -- | -41.18% | -84.13% | -99.43% |
| Net Income | 113.01% | -4.63% | -964.15% | 42.51% | -99.93% |
| EBIT | 220.61% | 4.49% | 277.80% | 98.92% | 151.68% |
| EBITDA | 112.81% | 20.58% | 91.55% | 160.39% | 408.86% |
| EPS Basic | 112.80% | -5.38% | -948.32% | 43.48% | -96.47% |
| Normalized Basic EPS | 162.17% | -48.67% | 564.62% | 43.52% | 65.75% |
| EPS Diluted | 111.37% | -5.38% | -914.87% | 43.48% | -96.47% |
| Normalized Diluted EPS | 160.22% | -48.67% | 549.23% | 43.52% | 65.75% |
| Average Basic Shares Outstanding | 1.59% | -0.68% | 1.52% | 1.70% | 1.79% |
| Average Diluted Shares Outstanding | 4.85% | -0.68% | 4.97% | 1.70% | 1.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |